{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:23:27Z","timestamp":1768317807352,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI103390"],"award-info":[{"award-number":["U01 AI103390"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00216-018-1394-y","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T01:24:10Z","timestamp":1538443450000},"page":"7773-7781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development and validation of an LC-MS\/MS assay for the quantification of dolutegravir extracted from human hair"],"prefix":"10.1007","volume":"410","author":[{"given":"Craig","family":"Sykes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Blake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda P","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan B.","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mackenzie L.","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bani","family":"Tamraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela D. M.","family":"Kashuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,2]]},"reference":[{"issue":"1","key":"1394_CR1","doi-asserted-by":"crossref","first-page":"ofx275","DOI":"10.1093\/ofid\/ofx275","volume":"5","author":"JR Castillo-Mancilla","year":"2017","unstructured":"Castillo-Mancilla JR, Phillips AN, Neaton JD, Neuhaus J, Collins S, Mannheimer S, et al. Association of suboptimal antiretroviral therapy adherence with inflammation in virologically suppressed individuals enrolled in the SMART study. INSIGHT SMART Study Group. Open Forum Infect Dis. 2017;5(1):ofx275.","journal-title":"Open Forum Infect Dis"},{"key":"1394_CR2","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Department of Health and Human Services. Available at http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/AdultandAdolescentGL.pdf ."},{"issue":"1","key":"1394_CR3","doi-asserted-by":"crossref","first-page":"e01710","DOI":"10.1128\/AAC.01710-17","volume":"62","author":"PL Anderson","year":"2017","unstructured":"Anderson PL, Liu AY, Castillo-Mancilla JR, Gardner EM, Seifert SM, McHugh C, et al. Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy. Antimicrob Agents Chemother. 2017;62(1):e01710\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1394_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1310\/hct0904-238","volume":"9","author":"TJ Podsadecki","year":"2008","unstructured":"Podsadecki TJ, Vrijens BC, Tousset EP, Rode RA, Hanna GJ. \u201cWhite coat compliance\u201d limits the reliability of therapeutic drug monitoring in HIV-1-infected patients. HIV Clin Trials. 2008;9(4):238\u201346.","journal-title":"HIV Clin Trials"},{"issue":"February (2)","key":"1394_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1089\/aid.2012.0089","volume":"29","author":"JR Castillo-Mancilla","year":"2013","unstructured":"Castillo-Mancilla JR, Zheng JH, Rower JE, Meditz A, Gardner EM, Predhomme J, et al. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res Hum Retrovir. 2013;29(February (2)):384\u201390.","journal-title":"AIDS Res Hum Retrovir"},{"key":"1394_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jpba.2017.10.030","volume":"149","author":"AP Schauer","year":"2017","unstructured":"Schauer AP, Sykes C, Cottrell ML, Prince H, Kashuba ADM. Validation of an LC-MS\/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots. J Pharm Biomed Anal. 2017;149:40\u20135.","journal-title":"J Pharm Biomed Anal"},{"issue":"10","key":"1394_CR7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/cid\/cir131","volume":"52","author":"M Gandhi","year":"2011","unstructured":"Gandhi M, Ameli N, Bacchetti P, Anastos K, Gange SJ, Minkoff H, et al. Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. Clin Infect Dis. 2011;52(10):1267\u201375.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1394_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/QAI.0b013e31820dc0cc","volume":"56","author":"GU van Zyl","year":"2011","unstructured":"van Zyl GU, van Mens TE, McIlleron H, Zeier M, Nachega JB, Decloedt E, et al. Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. J Acquir Immune Defic Syndr. 2011;56(4):333\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"1394_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/QAD.0b013e328325a4a9","volume":"23","author":"M Gandhi","year":"2009","unstructured":"Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, et al. Protease inhibitor levels in hair strongly predict virologic response to treatment. AIDS. 2009;23(4):471\u20138.","journal-title":"AIDS"},{"issue":"January (2)","key":"1394_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jchromb.2005.11.009","volume":"830","author":"Matuszewski","year":"2006","unstructured":"Matuszewski. Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. J Chromatogr B Anal Technol Biomed Life Sci. 2006;830(January (2)):293\u2013300.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"1\u20133","key":"1394_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.forsciint.2011.02.015","volume":"210","author":"MA LeBeau","year":"2011","unstructured":"LeBeau MA, Montgomery MA, Brewer JD. The role of variations in growth rate and sample collection on interpreting results of segmented analyses of hair. Forensic Sci Int. 2011;210(1\u20133):110\u20136.","journal-title":"Forensic Sci Int"},{"issue":"6","key":"1394_CR12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/jat\/22.6.406","volume":"22","author":"MH Slawson","year":"1998","unstructured":"Slawson MH, Wilkins DG, Rollins DE. The incorporation of drugs into hair: relationship of hair color and melanin concentration to phencyclidine incorporation. J Anal Toxicol. 1998;22(6):406\u201313.","journal-title":"J Anal Toxicol"},{"issue":"8","key":"1394_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/jat\/27.8.545","volume":"27","author":"DE Rollins","year":"2003","unstructured":"Rollins DE, Wilkins DG, Krueger GG, Augsburger MP, Mizuno A, O\u2019Neal C, et al. The effect of hair color on the incorporation of codeine into human hair. J Anal Toxicol. 2003;27(8):545\u201351.","journal-title":"J Anal Toxicol"},{"issue":"1\u20133","key":"1394_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0379-0738(96)02048-8","volume":"84","author":"M Rothe","year":"1997","unstructured":"Rothe M, Praqst F, Thor S, Hunger J. Effect of pigmentation on the drug deposition in hair of grey-haired subjects. Forensic Sci Int. 1997;84(1\u20133):53\u201360.","journal-title":"Forensic Sci Int"},{"key":"1394_CR15","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0090-9556(24)13675-6","volume":"28","author":"DL Hubbard","year":"2000","unstructured":"Hubbard DL, Wilkins DG, Rollins DE. The incorporation of cocaine and metabolites into hair: effects of dose and hair pigmentation. Drug Metab Dispos. 2000;28:1464\u20139.","journal-title":"Drug Metab Dispos"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-018-1394-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-1394-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-1394-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:07:05Z","timestamp":1761088025000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-018-1394-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,2]]},"references-count":15,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1394"],"URL":"https:\/\/doi.org\/10.1007\/s00216-018-1394-y","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,2]]},"assertion":[{"value":"14 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}